TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes

Autor: Raphael Schiffmann, Mona Bugaighis, Quasar S Padiath, Julian Curiel, Asako Takanohashi, Xiaoqin Fu, Judy S. Liu, Adeline Vanderver, Marjo S. van der Knaap, Guy Helman, Cas Simons, Guillermo Rodríguez Bey, Nicole I. Wolf, Marianna Bugiani, Bruce Nmezi, Tyler Mark Pierson
Přispěvatelé: Amsterdam Neuroscience - Cellular & Molecular Mechanisms, Pathology, Pediatric surgery
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Neurodegenerative
medicine.disease_cause
Bioinformatics
Microtubules
Medical and Health Sciences
Basal Ganglia
Myelin
0302 clinical medicine
Tubulin
Cerebellum
2.1 Biological and endogenous factors
Aetiology
Child
Myelin Sheath
Genetics (clinical)
Neurons
Genetics & Heredity
Mutation
Brain
Articles
General Medicine
Middle Aged
Biological Sciences
Magnetic Resonance Imaging
Phenotype
Cell biology
Oligodendroglia
medicine.anatomical_structure
Child
Preschool

Neurological
Female
Adult
Cell type
Adolescent
Biology
Cataract
Young Adult
03 medical and health sciences
Rare Diseases
Atrophy
Microtubule
Genetics
medicine
Humans
Preschool
Molecular Biology
Leukodystrophy
Neurosciences
Leukodystrophy
Metachromatic

Metachromatic
medicine.disease
Oligodendrocyte
Brain Disorders
Hereditary Central Nervous System Demyelinating Diseases
030104 developmental biology
Hela Cells
030217 neurology & neurosurgery
HeLa Cells
Zdroj: Human Molecular Genetics, 26(22), 4506-4518. Oxford University Press
Curiel, J, Bey, G R, Takanohashi, A, Bugiani, M, Fu, X, Wolf, N I, Nmezi, B, Schiffmann, R, Bugaighis, M, Pierson, T, Helman, G, Simons, C, van der Knaap, M S, Liu, J, Padiath, Q & Vanderver, A 2017, ' TUBB4A mutations result in specific neuronal and oligodendrocytic defects that closely match clinically distinct phenotypes ', Human Molecular Genetics, vol. 26, no. 22, pp. 4506-4518 . https://doi.org/10.1093/hmg/ddx338
Human molecular genetics, vol 26, iss 22
Hum Mol Genet
ISSN: 1460-2083
0964-6906
Popis: Hypomyelinating leukodystrophies are heritable disorders defined by lack of development of brain myelin, but the cellular mechanisms of hypomyelination are often poorly understood. Mutations in TUBB4A, encoding the tubulin isoform tubulin beta class IVA (Tubb4a), result in the symptom complex of hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC). Additionally, TUBB4A mutations are known to result in a broad phenotypic spectrum, ranging from primary dystonia (DYT4), isolated hypomyelination with spastic quadriplegia, and an infantile onset encephalopathy, suggesting multiple cell types may be involved. We present a study of the cellular effects of TUBB4A mutations responsible for H-ABC (p.Asp249Asn), DYT4 (p.Arg2Gly), a severe combined phenotype with hypomyelination and encephalopathy (p.Asn414Lys), as well as milder phenotypes causing isolated hypomyelination (p.Val255Ile and p.Arg282Pro). We used a combination of histopathological, biochemical and cellular approaches to determine how these different mutations may have variable cellular effects in neurons and/or oligodendrocytes. Our results demonstrate that specific mutations lead to either purely neuronal, combined neuronal and oligodendrocytic or purely oligodendrocytic defects that closely match their respective clinical phenotypes. Thus, the DYT4 mutation that leads to phenotypes attributable to neuronal dysfunction results in altered neuronal morphology, but with unchanged tubulin quantity and polymerization, with normal oligodendrocyte morphology and myelin gene expression. Conversely, mutations associated with isolated hypomyelination (p.Val255Ile and p.Arg282Pro) and the severe combined phenotype (p.Asn414Lys) resulted in normal neuronal morphology but were associated with altered oligodendrocyte morphology, myelin gene expression, and microtubule dysfunction. The H-ABC mutation (p.Asp249Asn) that exhibits a combined neuronal and myelin phenotype had overlapping cellular defects involving both neuronal and oligodendrocyte cell types in vitro. Only mutations causing hypomyelination phenotypes showed altered microtubule dynamics and acted through a dominant toxic gain of function mechanism. The DYT4 mutation had no impact on microtubule dynamics suggesting a distinct mechanism of action. In summary, the different clinical phenotypes associated with TUBB4A reflect the selective and specific cellular effects of the causative mutations. Cellular specificity of disease pathogenesis is relevant to developing targeted treatments for this disabling condition.
Databáze: OpenAIRE